Notify me when Freebird Partners LP files a new Schedule 13D/G report.
⭐ Subscribe ⭐| Sym | Company | Class | Ownership | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|---|
| ERNA | Ernexa Therapeutics Inc. | Common Stock, par value $0.005 per share | 9.9% | $1.18M | $204K | 6.21M | +20.9% | Freebird Partners LP | Mar 31, 2025 |
| Sym | Target | Class | Ownership | Change | Current Shares | Change | Value | Reporting name | Form | Report Period | Date Filed |
|---|